🟢 West Pharmaceutical Services is trading 4.65% up in pre-market after Q3 beat and raised full-year guidance

West Pharmaceutical Services is trading at $436.05, up 4.65% in pre-market after Q3 sales and adjusted EPS beat estimates and management raised guidance.

• October 29 results showed sales of $874.5 million and adjusted EPS of $2.66, both above estimates.
• Full-year guidance rose to $3.41–$3.42 billion in sales and $9.38–$9.48 in adjusted EPS.
• Shares also rose 3.23% in the October 29 session, before the current pre-market move.